Search: onr:"swepub:oai:DiVA.org:uu-170033" >
Pharmacogenetic war...
Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy
- Article/chapterEnglish2012
Publisher, publication year, extent ...
Numbers
-
LIBRIS-ID:oai:DiVA.org:uu-170033
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-170033URI
-
https://doi.org/10.1160/TH11-06-0388DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:124177567URI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
By guiding initial warfarin dose, pharmacogenetic (PGx) algorithms may improve the safety of warfarin initiation. However, once international normalised ratio (INR) response is known, the contribution of PGx to dose refinements is uncertain. This study sought to develop and validate clinical and PGx dosing algorithms for warfarin dose refinement on days 6-11 after therapy initiation. An international sample of 2,022 patients at 13 medical centres on three continents provided clinical, INR, and genetic data at treatment days 6-11 to predict therapeutic warfarin dose. Independent derivation and retrospective validation samples were composed by randomly dividing the population (80%/20%). Prior warfarin doses were weighted by their expected effect on S-warfarin concentrations using an exponential-decay pharmacokinetic model. The INR divided by that "effective" dose constituted a treatment response index . Treatment response index, age, amiodarone, body surface area, warfarin indication, and target INR were associated with dose in the derivation sample. A clinical algorithm based on these factors was remarkably accurate: in the retrospective validation cohort its R2 was 61.2% and median absolute error (MAE) was 5.0 mg/week. Accuracy and safety was confirmed in a prospective cohort (N=43). CYP2C9 variants and VKORC1-1639 G→A were significant dose predictors in both the derivation and validation samples. In the retrospective validation cohort, the PGx algorithm had: R2= 69.1% (p<0.05 vs. clinical algorithm), MAE= 4.7 mg/week. In conclusion, a pharmacogenetic warfarin dose-refinement algorithm based on clinical, INR, and genetic factors can explain at least 69.1% of therapeutic warfarin dose variability after about one week of therapy.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Lenzini, P A
(author)
-
Wadelius, MiaUppsala universitet,Klinisk farmakogenomik och osteoporos(Swepub:uu)miawadel
(author)
-
Jorgensen, A L
(author)
-
Kimmel, S E
(author)
-
Ridker, P M
(author)
-
Eriksson, NiclasUppsala universitet,Uppsala kliniska forskningscentrum (UCR),Clinical pharmacogenomics(Swepub:uu)nieri103
(author)
-
Anderson, J L
(author)
-
Pirmohamed, M
(author)
-
Limdi, N A
(author)
-
Pendleton, R C
(author)
-
McMillin, G A
(author)
-
Burmester, J K
(author)
-
Kurnik, D
(author)
-
Stein, C M
(author)
-
Caldwell, M D
(author)
-
Eby, C S
(author)
-
Rane, AKarolinska Institutet
(author)
-
Lindh, J DKarolinska Institutet
(author)
-
Shin, J-G
(author)
-
Kim, H-S
(author)
-
Angchaisuksiri, P
(author)
-
Glynn, R J
(author)
-
Kronquist, K E
(author)
-
Carlquist, J F
(author)
-
Grice, G R
(author)
-
Barrack, R L
(author)
-
Li, J
(author)
-
Gage, B F
(author)
-
Uppsala universitetKlinisk farmakogenomik och osteoporos
(creator_code:org_t)
Related titles
-
In:Thrombosis and Haemostasis107:2, s. 232-2400340-62452567-689X
Internet link
Find in a library
To the university's database
- By the author/editor
-
Horne, B D
-
Lenzini, P A
-
Wadelius, Mia
-
Jorgensen, A L
-
Kimmel, S E
-
Ridker, P M
-
show more...
-
Eriksson, Niclas
-
Anderson, J L
-
Pirmohamed, M
-
Limdi, N A
-
Pendleton, R C
-
McMillin, G A
-
Burmester, J K
-
Kurnik, D
-
Stein, C M
-
Caldwell, M D
-
Eby, C S
-
Rane, A
-
Lindh, J D
-
Shin, J-G
-
Kim, H-S
-
Angchaisuksiri, ...
-
Glynn, R J
-
Kronquist, K E
-
Carlquist, J F
-
Grice, G R
-
Barrack, R L
-
Li, J
-
Gage, B F
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Clinical Laborat ...
- Articles in the publication
-
Thrombosis and H ...
- By the university
-
Uppsala University
-
Karolinska Institutet